Myoma RFA

An outpatient alternative to hysterectomy and myomectomy.^1-6

Uterine Fibroid Ablation Success, Built On a Legacy of RFA Innovation

Radiofrequency ablation (RFA) is a minimally invasive, outpatient, uterine-preserving alternative to myomectomy and hysterectomy for the treatment of uterine fibroids. RFA can reduce the size of leiomyoma and improve symptoms and quality of life.^1-6

Real-Time Audiovisual Feedback

Hear and see impedance changes during radiofrequency ablation procedure so you can keep your eyes on the ultrasound and patient.

Hands-Free Generator Operation

With an intuitive footswitch and pump synchronization, the RF generator frees your hands for the electrode and ultrasound transducer.

Automatic Electronic Records

The RF generator automatically logs readings for hundreds of procedures for easy record keeping and analysis.

Generator-Pump Synchronization

Real-time temperature monitoring during and after RF output delivery to monitor electrode cooling and verify tissue heating.

Specialized Control Features

Adjustable controls for impedance and temperature help standardize treatment and limit tissue charring.

A Major Upgrade to Trusted Technology

RFA Generator

With an interface and controls optimized for the moving shot technique, the CRF Generator is a trusted copilot for clinicians performing uterine fibroid RFA procedures.

CRF Electrodes Help Clinicians Hit the Target

For uterine fibroids of varying size and FIGO type, clinicians trust the CRF RFA System’s cooled electrodes to hit the mark with precise treatment.

Sharp: The CRF electrode’s sharp tip and smooth insulation can penetrate tissue and fibroids with ease.

Ergonomic: The CRF electrode’s lightweight, low-profile hub and lightweight cable facilitate electrode placement and reduce potential disturbances.

Visible: The CRF electrode shows up clearly on ultrasound imaging and has shaft marks to indicate insertion depth.

Versatile: 17G, 1-3 cm tips, up to 27cm shafts, and other size options for diverse target sizes and approaches.

Myoma Ablation Success Starts Here

The CRF RFA System is tailored for myoma ablation success. Its powerful, easy-to-use generator helps the doctor focus on the ultrasound and patient during ablation. Its low-profile cooled electrodes enhance access and ergonomics. The CRF system is trusted to make uterine fibroid ablation more simple and efficient.

Download the brochure to see how the CRF RFA System’s innovation can lead the way for your leiomyoma ablation program.

Get Started with Cambridge CRF

See how the RFA System from Cambridge Interventional transforms tissue ablation with leading precision and power.

References

Santalla-Hernández et al. Clinical outcomes after 2-year follow-up of transvaginal radiofrequency ablation of symptomatic uterine fibroids. J Obstet Gynaecol Res. 2025 Jan;51(1):e16216.
Taheri et al. Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions. Int J Hyperthermia. 2019;36(1):295-301.
Andersson et al. Minimally Invasive Management of Uterine Fibroids – Role of Transvaginal Radiofrequency Ablation. J Reprod Med Gynecol Obstet 2024;9.
Chen et al. Radiofrequency Ablation for the Treatment of Uterine Fibroids: A Systematic Review and Meta-Analysis by the AAGL Practice Committee. J Minim Invasive Gynecol. 2025 Jan;32(1):74-91.
ACOG Practice Bulletin No. 228: Management of Symptomatic Uterine Leiomyomas: Correction. Obstet Gynecol. 2021 Oct 1;138(4):683.
Havryliuk Y, Setton R, Carlow JJ, Shaktman BD. Symptomatic Fibroid Management: Systematic Review of the Literature. JSLS. 2017 Jul-Sep;21(3):e2017.00041.